These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 29158557)

  • 1. MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells.
    Botta C; Cucè M; Pitari MR; Caracciolo D; Gullà A; Morelli E; Riillo C; Biamonte L; Gallo Cantafio ME; Prabhala R; Mignogna C; Di Vito A; Altomare E; Amodio N; Di Martino MT; Correale P; Rossi M; Giordano A; Munshi NC; Tagliaferri P; Tassone P
    Leukemia; 2018 Apr; 32(4):1003-1015. PubMed ID: 29158557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.
    Zhao H; Wilkie T; Deol Y; Sneh A; Ganju A; Basree M; Nasser MW; Ganju RK
    Mol Cancer; 2015 Jan; 14():11. PubMed ID: 25622979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of microRNA-29b induces apoptosis of multiple myeloma cells through down regulating Mcl-1.
    Zhang YK; Wang H; Leng Y; Li ZL; Yang YF; Xiao FJ; Li QF; Chen XQ; Wang LS
    Biochem Biophys Res Commun; 2011 Oct; 414(1):233-9. PubMed ID: 21951844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genistein inhibits the proliferation of human multiple myeloma cells through suppression of nuclear factor-κB and upregulation of microRNA-29b.
    Xie J; Wang J; Zhu B
    Mol Med Rep; 2016 Feb; 13(2):1627-32. PubMed ID: 26718793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma.
    Amodio N; Leotta M; Bellizzi D; Di Martino MT; D'Aquila P; Lionetti M; Fabiani F; Leone E; Gullà AM; Passarino G; Caraglia M; Negrini M; Neri A; Giordano A; Tagliaferri P; Tassone P
    Oncotarget; 2012 Oct; 3(10):1246-58. PubMed ID: 23100393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells.
    Amodio N; Bellizzi D; Leotta M; Raimondi L; Biamonte L; D'Aquila P; Di Martino MT; Calimeri T; Rossi M; Lionetti M; Leone E; Passarino G; Neri A; Giordano A; Tagliaferri P; Tassone P
    Cell Cycle; 2013 Dec; 12(23):3650-62. PubMed ID: 24091729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-29b inhibits the progression of multiple myeloma through downregulating FOXP1.
    Wang H; Ding Q; Wang M; Guo M; Zhao Q
    Hematology; 2019 Dec; 24(1):32-38. PubMed ID: 30068241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple Myeloma.
    Amodio N; Stamato MA; Gullà AM; Morelli E; Romeo E; Raimondi L; Pitari MR; Ferrandino I; Misso G; Caraglia M; Perrotta I; Neri A; Fulciniti M; Rolfo C; Anderson KC; Munshi NC; Tagliaferri P; Tassone P
    Mol Cancer Ther; 2016 Jun; 15(6):1364-75. PubMed ID: 27196750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative analysis of differential miRNA and functional study of miR-21 by seed-targeting inhibition in multiple myeloma cells in response to berberine.
    Luo X; Gu J; Zhu R; Feng M; Zhu X; Li Y; Fei J
    BMC Syst Biol; 2014 Jul; 8():82. PubMed ID: 25000828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1.
    Amodio N; Di Martino MT; Foresta U; Leone E; Lionetti M; Leotta M; Gullà AM; Pitari MR; Conforti F; Rossi M; Agosti V; Fulciniti M; Misso G; Morabito F; Ferrarini M; Neri A; Caraglia M; Munshi NC; Anderson KC; Tagliaferri P; Tassone P
    Cell Death Dis; 2012 Nov; 3(11):e436. PubMed ID: 23190608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
    Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
    PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth.
    Leone E; Morelli E; Di Martino MT; Amodio N; Foresta U; Gullà A; Rossi M; Neri A; Giordano A; Munshi NC; Anderson KC; Tagliaferri P; Tassone P
    Clin Cancer Res; 2013 Apr; 19(8):2096-106. PubMed ID: 23446999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-181d regulates human dendritic cell maturation through NF-κB pathway.
    Su XW; Lu G; Leung CK; Liu Q; Li Y; Tsang KS; Zhao SD; Chan DTM; Kung HF; Poon WS
    Cell Prolif; 2017 Oct; 50(5):. PubMed ID: 28731516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-29b negatively regulates human osteoclastic cell differentiation and function: implications for the treatment of multiple myeloma-related bone disease.
    Rossi M; Pitari MR; Amodio N; Di Martino MT; Conforti F; Leone E; Botta C; Paolino FM; Del Giudice T; Iuliano E; Caraglia M; Ferrarini M; Giordano A; Tagliaferri P; Tassone P
    J Cell Physiol; 2013 Jul; 228(7):1506-15. PubMed ID: 23254643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cell-mediated activation-induced cytidine deaminase (AID)-dependent induction of genomic instability in human myeloma.
    Koduru S; Wong E; Strowig T; Sundaram R; Zhang L; Strout MP; Flavell RA; Schatz DG; Dhodapkar KM; Dhodapkar MV
    Blood; 2012 Mar; 119(10):2302-9. PubMed ID: 22234692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A miR-29b Byproduct Sequence Exhibits Potent Tumor-Suppressive Activities via Inhibition of NF-κB Signaling in
    Inoue A; Mizushima T; Wu X; Okuzaki D; Kambara N; Ishikawa S; Wang J; Qian Y; Hirose H; Yokoyama Y; Ikeshima R; Hiraki M; Miyoshi N; Takahashi H; Haraguchi N; Hata T; Matsuda C; Doki Y; Mori M; Yamamoto H
    Mol Cancer Ther; 2018 May; 17(5):977-987. PubMed ID: 29545333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-29b promotes cell sensitivity to Temozolomide by targeting STAT3 in glioma.
    Xu JX; Yang Y; Zhang X; Luan XP
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1922-1931. PubMed ID: 32141561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma.
    Rossi M; Altomare E; Botta C; Gallo Cantafio ME; Sarvide S; Caracciolo D; Riillo C; Gaspari M; Taverna D; Conforti F; Critelli P; Bertucci B; Iannone M; Polerà N; Scumaci D; Arbitrio M; Amodio N; Di Martino MT; Paiva B; Tagliaferri P; Tassone P
    Leukemia; 2021 Mar; 35(3):823-834. PubMed ID: 32632096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ibrutinib targets microRNA-21 in multiple myeloma cells by inhibiting NF-κB and STAT3.
    Ma J; Gong W; Liu S; Li Q; Guo M; Wang J; Wang S; Chen N; Wang Y; Liu Q; Zhao H
    Tumour Biol; 2018 Jan; 40(1):1010428317731369. PubMed ID: 29320977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.